DCM
Driehaus Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136M | Sell |
4,335,648
-249,211
| -5% | -$7.8M | 1.09% | 9 |
|
|
2025
Q1 | $154M | Buy |
4,584,859
+64,264
| +1% | +$2.16M | 1.48% | 4 |
|
|
2024
Q4 | $177M | Sell |
4,520,595
-75,126
| -2% | -$2.94M | 1.46% | 4 |
|
|
2024
Q3 | $181M | Buy |
4,595,721
+176,249
| +4% | +$6.94M | 1.55% | 7 |
|
|
2024
Q2 | $172M | Buy |
4,419,472
+97,732
| +2% | +$3.81M | 1.67% | 6 |
|
|
2024
Q1 | $186M | Sell |
4,321,740
-23,440
| -0.5% | -$1.01M | 1.85% | 4 |
|
|
2023
Q4 | $200M | Sell |
4,345,180
-167,825
| -4% | -$7.73M | 2.41% | 2 |
|
|
2023
Q3 | $154M | Sell |
4,513,005
-247,848
| -5% | -$8.47M | 2% | 3 |
|
|
2023
Q2 | $183M | Buy |
4,760,853
+105,928
| +2% | +$4.08M | 2.31% | 2 |
|
|
2023
Q1 | $167M | Sell |
4,654,925
-26,872
| -0.6% | -$962K | 2.34% | 2 |
|
|
2022
Q4 | $185M | Buy |
4,681,797
+177,777
| +4% | +$7.01M | 2.75% | 2 |
|
|
2022
Q3 | $163M | Buy |
4,504,020
+112,982
| +3% | +$4.08M | 2.46% | 2 |
|
|
2022
Q2 | $134M | Buy |
4,391,038
+1,090,611
| +33% | +$33.2M | 2.16% | 2 |
|
|
2022
Q1 | $101M | Buy |
3,300,427
+177,198
| +6% | +$5.42M | 1.24% | 7 |
|
|
2021
Q4 | $97.6M | Buy |
3,123,229
+1,611,686
| +107% | +$50.3M | 1% | 16 |
|
|
2021
Q3 | $23.1M | Buy |
1,511,543
+566,408
| +60% | +$8.65M | 0.27% | 116 |
|
|
2021
Q2 | $17.6M | Buy |
945,135
+173,725
| +23% | +$3.23M | 0.23% | 143 |
|
|
2021
Q1 | $13.8M | Buy |
771,410
+325,966
| +73% | +$5.83M | 0.2% | 152 |
|
|
2020
Q4 | $6.85M | Sell |
445,444
-5,863
| -1% | -$90.2K | 0.11% | 216 |
|
|
2020
Q3 | $5M | Sell |
451,307
-12,926
| -3% | -$143K | 0.1% | 206 |
|
|
2020
Q2 | $5.82M | Buy |
464,233
+1,901
| +0.4% | +$23.8K | 0.14% | 174 |
|
|
2020
Q1 | $5.24M | Buy |
+462,332
| New | +$5.24M | 0.18% | 141 |
|